Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-11

FDA Approved: PIRFENIDONE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for pirfenidone from Teva Pharmaceuticals, Inc., supporting a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

SUPPL AP for PIRFENIDONE (PIRFENIDONE)